Certified Gastroenterology Registered Nurse Practice Exam

Cupramine is specifically indicated for the treatment of Wilson’s disease, a genetic disorder that leads to excessive accumulation of copper in the body. This condition is caused by a defect in copper metabolism, resulting in toxic levels of copper primarily affecting the liver and brain. Cupramine, which contains penicillamine, acts as a chelating agent, binding to copper so it can be excreted from the body, thereby reducing the harmful effects of copper overload.

In contrast, conditions like hemochromatosis relate to iron overload rather than copper, and would therefore not respond to treatment with Cupramine. Copper deficiency would not require the use of a chelating agent like Cupramine, as that condition would necessitate supplementation rather than reduction of copper. Neuropathy can arise from various causes but is not directly treated with Cupramine, particularly if it is not linked to Wilson's disease. Thus, Wilson's disease is the condition specifically addressed by the use of Cupramine.